Cancer treatment in Kenya has long carried a double burden for patients: the devastating toll of the disease and the financial and systemic hurdles that stand between them and timely medical care.
The Ministry of Health has unveiled the National Cancer Treatment Guidelines 2026, marking the first major revision of the country’s cancer treatment protocols since 2019.
The new guidelines seek to standardise cancer care across the country, strengthen patient protection and improve access to specialised treatment, with nearly 45,000 Kenyans diagnosed with cancer annually.
The reforms also introduce stricter timelines for diagnosis and treatment while linking cancer care directly to the Social Health Authority’s (SHA) digital oncology module to improve accountability in the management of the Ksh800,000 oncology benefit.
Health Cabinet Secretary Aden Duale said the digital system would establish a unified patient record accessible across healthcare facilities, addressing fragmented care and duplication of medical records.
“The cancer patient will have one unified oncology record across all facilities. For the benefit of the cancer patient in our country, we’ll eliminate duplicate records and we’ll eliminate fragmented care. We will have better coordination. There will be better management of even the Ksh800,000 oncology benefit. Because they must get safer treatment, specialist supervision and better patient outcomes,” Duale said.
The Ksh800,000 oncology benefit has been a major point of concern among cancer patients, some of whom have complained of exhausting their insurance allocation before completing treatment.
Patients have raised concerns over inflated hospital bills, unnecessary procedures and delays in the approval of treatment, forcing some to seek additional funds out of pocket.
One cancer patient described the frustration of waiting for treatment only to discover that SHA had not approved the required services.
“Mgonjwa anangoja. Amefika hospitali. Aambiwe ya kwamba sasa SHA imekata ku-approve tangu asubuhi hadi masaa ya jioni. Mtu umeketi tu hapo ukiwa na matumaini na mwisho unapata ya kwamba umekuwa frustrated,” the patient said.
The Ministry of Health and SHA have consequently warned contracted healthcare facilities against practices that unnecessarily deplete patients’ allocated benefits.
Officials say some hospitals have been accused of consuming patients’ allocations through unnecessary services before asking them to make additional payments despite having an active oncology benefit.
The government says the new digital oncology module will help monitor treatment, improve accountability and ensure patients receive services covered under their benefits.
Officials have also challenged healthcare facilities to justify their charges and ensure patients are not subjected to unnecessary medical procedures.
SHA Chairman Abdi Mohamed said the authority had received complaints from patients concerning questionable billing practices, including charges for services that were allegedly never provided.
“Patients are writing to us through me, but when you look at people who plead on behalf of daughters, consultation where there is not even a doctor and there was no consultation,” he said.
He called for accountability in the healthcare system, urging stakeholders to establish clear alternatives when disagreements arise over the cost of treatment and approved charges.
Beyond financing, the 2026 guidelines introduce strict timelines intended to reduce delays in cancer diagnosis and treatment.
Under the new protocols:
The timelines are intended to ensure patients move through the healthcare system faster, reducing the risk of advanced disease caused by prolonged waiting periods.
The 2026 guidelines also incorporate medical advances that were not widely embedded in the inaugural 2019 protocols.
The updated manual provides for modern cancer treatment approaches, including molecular profiling, targeted therapies and immunotherapies.
These interventions are intended to improve the accuracy of diagnosis and enable specialists to select treatments based on the characteristics of individual cancers.
The guidelines also expand paediatric cancer treatment protocols, providing dedicated pathways for the nearly 2,300 children and adolescents diagnosed annually.
Under the new framework, children diagnosed with cancer must be referred to specialised centres of excellence within 14 days to facilitate access to appropriate treatment.
The revised protocols also introduce guidance on managing oncological emergencies, including life-threatening complications such as sepsis and spinal cord compression.
They establish mandatory safety standards for administering chemotherapy drugs, which require careful handling and specialist supervision because of their toxicity.
Another major change is the integration of palliative care and pain management from the point of diagnosis rather than waiting until the final stages of the disease.
The guidelines further introduce structured survivorship plans to support patients after completing treatment, addressing their long-term health and recovery needs.
Kenya records more than 44,000 new cancer cases annually, with the disease remaining the country’s third-leading cause of death.
The 2026 guidelines seek to address longstanding inequalities in cancer care by ensuring patients receive standardised treatment regardless of their geographical location or financial circumstances.
However, their success will depend on implementation, including the availability of specialists, diagnostic equipment, medicines and functional referral systems across the country.
For thousands of Kenyan families confronting a cancer diagnosis, the real measure of the new guidelines will be whether they translate into faster diagnosis, transparent hospital bills and uninterrupted access to treatment.

Leave a Reply